Agmatine, the natural metabolite of the amino acid arginine, has previously been reported to support nerve health (Pain Medicine, 2010, Vol. 11, pp. 356-368), and the new patent (#8916612) is a “very significant and important landmark achievement for Gilad&Gilad”, said the company.
"This patent is of considerable value to our company in providing protection to our discoveries and investments. And based on recent scientific evidence, a continuation patent expanding the scope of the initial claims to additional indications is now pending," said Gilad&Gilad's CEO, Dr Gad Gilad.
Gilad&Gilad LLC manufactures and markets the For-Nerve-Health line of products containing its proprietary G-Agmatine brand.
According to Dr Gilad, there is a scarcity of dietary ingredients that support healthy nerve functions. "There is an unmet need for a safe and effective supplement by millions of Americans who are coping everyday with great challenges to their nervous system health and with threats to maintaining resilient nerve functions," hesaid.
As to the question of other indications, Dr. Gilad said that "for now, there are no additional indications which are backed by clinical studies. That agmatine is touted for bodybuilding, is completely unsubstantiated and is backed by outright false claims."